Primary Record
Estropipate
- In stock
- 2,620 g
- Purity
- 98.1 %
- CAS
- 7280-37-7
Compound Identifiers & Properties
- CAS
- 7280-37-7
- PubChem CID
- 5284555
- SMILES
- C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)O.C1CNCCN1
- Canonical SMILES
- C1CNCCN1.C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)O)cc4CC[C@H]3[C@@H]1CCC2=O
Names & Synonyms
- Estropipate
- Ogen
- Piperazine estrone sulfate
- Harmogen
- Sulestrex
- Ortho-Est
- 7280-37-7
- Harmonet
- Genoral
- Sulestrex piperazine
- Piperazine estronesulfate
- Estropipate (USP)
- Estropipate [USAN]
- piperazine estrone sulphate
- OGEN 5
- Ogen (TN)
- Piperazineestronesulfate
- Estrone sulfate piperazine salt
- Estropipate (Standard)
- UNII-SVI38UY019
- RefChem:55152
- DTXSID3023005
- OGEN 2.5
- SVI38UY019
- Estrone sulphate piperazine
- D03IUY
- Estropipate [USP:INN:BAN]
- ESTROPIPATE [VANDF]
- OGEN .625
- OGEN 1.25
- Piperazine oestrone sulphate
- AC1NR4O7
- CHEBI:4873
- DTXCID303005
- ESTROPIPATE [MART.]
- SCHEMBL21577
- ESTROPIPATE [USP-RS]
- ESTROPIPATE [WHO-DD]
- C22H32N2O5S
- MLS002153957
- CHEMBL1200980
- NSC-758912
- SCHEMBL29366794
- CTK8F9509
- EINECS 230-696-3
- ERK5-3E22
- HY-B1361R
- ESTROPIPATE [ORANGE BOOK]
- HZEQBCVBILBTEP-ZFINNJDLSA-N
- MFCD00867399
- HMS1570I17
- HMS2097I17
- HMS2232O19
- HMS3714I17
- ESTROPIPATE [USP MONOGRAPH]
- BCP05424
- HY-B1361
- C18H22O5S.C4H10N2
- Tox21_113350
- s5288
- AKOS024457702
- BCP9000662
- CCG-220688
- CID5284555
- CM14419
- CS-4818
- EBC-127028
- Estropipate, >=98% (HPLC), powder
- NSC 758912
- CID:5284555
- NCGC00016682-02
- SID:96099890
- SMR001233296
- CAS-7280-37-7
- Conjugated estrogens: piperazine estrone sulfate
- AM20080957
- C18-H22-O5-S.C4-H10-N2
- ESTRONE SULFATE PIPERAZINE SALT [MI]
- FT-0630365
- NS00080724
- ST24048920
- Estrone hydrogen sulfate compound with piperazine (1:1)
- A12796
- D00948
- Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1)
- 280E377
- A837628
- C009927
- Piperazine, compd. with estrone hydrogen sulfate (1:1)
- SR-01000000235
- Estrone, hydrogen sulfate, compd. with piperazine (1:1)
- Q5401860
- SR-01000000235-5
- Estrone Hydrogen Sulfate compound with Piperazine(1:1)
- Estra-1,3,5(10)-trien-17-one 3-sulphate piperazine (1:1)
- Estra-1,3,5(10)-trien-17-one 3-sulphate, compound with piperazine (1:1)
- Piperazine, compd. with 3-(sulfooxy)estra-1,3,5(10)-trien-17-one (1:1)
- 3-(Sulfooxy)-estra-1,3,5(10)-trien-17-one : piperazine (1:1)
- ESTRONE HYDROGEN SULPHATE COMPOUND WITH PIPERAZINE (1:1)
- Estropipate, United States Pharmacopeia (USP) Reference Standard
- [(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine
- 17-oxoestra-1,3,5(10)-trien-3-yl hydrogen sulfate - piperazine (1:1)
- 17-Oxoestra-1,3,5(10)-trien-3-yl hydrogen sulfate--piperazine (1/1)
- Piperazine, compound with 3-(Sulfooxy)estra-1,3,5(10)-trien-17-one(1:1)
- Estra-1,3,5(10)-trien-17-one,3-(sulfooxy)-,compd. with piperazine (1:1)
- Ortho-Est, Estra-1,3,5(10)-trien-17-one 3-sulphate, compound with Piperazine(1:1)
- [(8R,9S,13S,14S)-13-methyl-17-oxidanylidene-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate; piperazine
- [(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate,piperazine
- [(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate; piperazine
- 477-24-7
- Estra-1,3,5(10)-trien-17-one, 3-(sulfooxy)-, compd. with piperazine (1:1); Estrone, hydrogen sulfate, compd. with piperazine (1:1) (8CI); Piperazine, compd. with 3-(sulfooxy)estra-1,3,5(10)-trien-17-one (1:1) (9CI); Piperazine, compd. with estrone hydrogen sulfate (1:1) (8CI); 3-Sulfatoxyestra-1,3,5(10)-trien-17-one piperazine salt; Estrone sulfate piperazine salt; Estropipate; Harmogen; Ogen; Piperazine estrone sulfate; Sulestrex; Sulestrex piperazine
- piperazine (8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl sulfate
- piperazine; sulfuric acid [(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] ester